Clinical Care Options Oncology - Research Update on PARP Inhibition: Emerging Data in Breast, Ovarian, and Other Cancers - Virtual Presentation Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, May 08, 2010

Clinical Care Options Oncology - Research Update on PARP Inhibition: Emerging Data in Breast, Ovarian, and Other Cancers - Virtual Presentation



Note:  free access/register

Research Update on PARP Inhibition: Emerging Data in Breast, Ovarian, and Other Cancers

In this Interactive Virtual Presentation, William J. Gradishar, MD, FACP, reviews the mechanism of PARP inhibition and its rationale as a therapeutic pathway and describes recent data using novel PARP inhibitors.
Throughout this presentation, you will be invited to vote on treatment options for specific patient cases. After voting, you can graphically view how others have voted while Dr. Gradishar provides an evidence-based rationale for the choices.
To begin this Interactive Virtual Presentation, click here.
Downloadable Slideset
The slideset that accompanies this Interactive Virtual Presentation is available for use as a self-study resource or in your own noncommercial talks. To download, click here.
This CME-certified Interactive Virtual Presentation is located online at:
http://clinicaloptions.com/Oncology/Treatment%20Updates/PARP%20Inhibition.aspx

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.